TGTX icon

TG Therapeutics
TGTX

Overview Fund Trends Analyst Outlook Journalist POV

91 hedge funds and large institutions have $178M invested in TG Therapeutics in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

29% less capital invested

Capital invested by funds: $250M → $178M (-$71.2M)

88% less call options, than puts

Call options by funds: $115K | Put options by funds: $962K

Holders
91
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$115K
Puts
$962K
Net Calls
Net Calls Change

Top Buyers

1
+$11.3M
2
+$8.07M
3
+$1.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$925K
5
CS
Credit Suisse
Switzerland
+$924K

Top Sellers

1
-$13M
2
-$7.06M
3
-$4.47M
4
State Street
State Street
Massachusetts
-$3.37M
5
OM
Opaleye Management
Massachusetts
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$12K
77
$11K
78
$10K
79
$8.7K
80
$7K
81
$5K
82
$3K
83
$3K
84
$2K
85
$2K
86
$1K
87
$1K
88
$1K
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
98
–
1 2 3
4